Minimally invasive plate osteosynthesis for short oblique diaphyseal tibia fractures: Does fracture site affect the outcomes?
Date
2020-10-22
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Sage Publications
Abstract
Objective
To report the results of patients with short oblique diaphyseal tibia fractures treated with minimally invasive plate osteosynthesis (MIPO). The secondary aim was to understand the effect of fracture location (midshaft or distal 1/3) on outcomes.
Methods
Twenty-eight patients with short oblique (>30 degrees) tibial shaft fractures (AO/OTA 42A2) treated with plate and MIPO technique between 2015 and 2019 were retrospectively assessed. Age, gender, follow-up time, fracture type (open or closed), operation time, postoperative infection rate, union time, ankle joint range of motion, and complications were analyzed. Patients' radiographs at a minimum 1-year follow-up were evaluated for malunion, nonunion, and implant-related complications.
Results
Mean age and follow-up time were 47.0 +/- 15.7 years and 18.3 +/- 12.1 months, respectively. Mean bone union time was 3.66 +/- 1.04 months in middle 1/3 diaphysis and 4.23 +/- 1.48 months in distal 1/3 tibia fractures. Seven (25%) patients developed superficial infections. Mean union time, malunion rate, coronal and sagittal angulation, operation length, and infection rate were similar between the groups.
Conclusion
MIPO is an effective method for treatment of short oblique diaphyseal tibia fractures, and results in few complications. Both distal and midshaft fractures have similar union and malunion rates.
Description
Keywords
Tibia fracture, Minimally invasive percutaneous osteosynthesis, Plate osteosynthesis, Bone union, Nonunion, Malunion, Single-center, Distal meta, Metaphyseal, Research & experimental medicine, Pharmacology & pharmacy
Citation
Eken, G. vd. (2020). "Minimally invasive plate osteosynthesis for short oblique diaphyseal tibia fractures: Does fracture site affect the outcomes?". Journal of International Medical Research, 48(10).